Page 1529 - Small Animal Internal Medicine, 6th Edition
P. 1529
CHAPTER 96 Polysystemic Viral Diseases 1501
Collado VM, et al. Effect of type I interferons on the expression of Krecic MR, et al. Diagnostic performances of two rapid tests for
feline leukaemia virus. Vet Microbiol. 2007;123:180. detection of feline leukemia virus antigen in sera of experi-
VetBooks.ir feline immunodeficiency virus in cats with abscesses or bite Liu J, et al. Evaluation of rapid diagnostic test kits for feline leuke-
mentally feline leukemia virus-infected cats. JFMS Open Rep.
Goldkamp CE, et al. Seroprevalences of feline leukemia virus and
2018;4:2055116917748117.
wounds and rate of veterinarian compliance with current guide-
lines for retrovirus testing. J Am Vet Med Assoc. 2008;232:1152. mia virus infection using samples from naturally infected cats.
Grosenbaugh DA, et al. Efficacy of a nonadjuvanted recombinant JFMS Open Rep. 2016;2:2055116916667757.
FeLV vaccine and two inactivated FeLV vaccines when subject Lutz H, et al. Feline leukaemia. ABCD guidelines on prevention
to consistent virulent FeLV challenge conditions. Biologicals. and management. J Feline Med Surg. 2009;11:565.
2017;49:76. Nesina S, et al. Retroviral DNA–the silent winner: blood trans-
Hartmann K. Efficacy of antiviral chemotherapy for retrovirus- fusion containing latent feline leukemia provirus causes infection
infected cats: what does the current literature tell us? J Feline and disease in naïve recipient cats. Retrovirology. 2015;12:105.
Med Surg. 2015;17:925. Powers JA, et al. Feline leukemia virus disease outcomes in a
Hartmann K, et al. Quality of different in-clinic test systems for domestic cat breeding colony: relationship to endogenous FeLV
feline immunodeficiency virus and feline leukaemia virus infec- and other chronic viral infections. J Virol. 2018;doi:10.1128/
tion. J Feline Med Surg. 2007;Jun 30, [Epub ahead of print]. JVI.00649-18. pii: JVI.00649-18.
Hartmann K, et al. Treatment of feline leukemia virus-infected Reinacher M. Diseases associated with spontaneous feline leuke-
cats with paramunity inducer. Vet Immunol Immunopathol. mia virus (FeLV) infection in cats. Vet Immunol Immunopathol.
1998;65:267. 1989;21:85.
Hartmann K, et al. Treatment of feline leukemia virus infection with Stützer B, et al. Role of latent feline leukemia virus infection in
3’-azido-2,3-dideoxythymidine and human alpha-interferon. J nonregenerative cytopenias of cats. J Vet Intern Med. 2010;24:
Vet Intern Med. 2002;16:345. 192.
Helfer-Hungerbuehler AK, et al. Long-term follow up of feline leu- Torres AN, et al. Development and application of a quantitative
kemia virus infection and characterization of viral RNA loads real-time PCR assay to detect feline leukemia virus RNA. Vet
using molecular methods in tissues of cats with different infec- Immunol Immunopathol. 2008;123:81.
tion outcomes. Virus Res. 2015;197:137. Torres AN, et al. Re-examination of feline leukemia virus: host
Herring ES, et al. Detection of feline leukaemia virus in blood and relationships using realtime PCR. Virology. 2005;332:272.
bone marrow of cats with varying suspicion of latent infection. J Vobis M, et al. Experimental quantification of the feline leukaemia
Fel Med Surg. 2001;3:133. virus in the cat flea (Ctenocephalides felis) and its faeces. Para-
Hofmann-Lehmann R, et al. Vaccination against the feline leu- sitol Res. 2005;1:S102.
kaemia virus: outcome and response categories and long-term Wardrop KJ, et al. Update on canine and feline blood donor screen-
follow-up. Vaccine. 2007;25:5531. ing for blood-borne pathogens. J Vet Intern Med. 2016;30:15.
Jirjis F, et al. Protection against feline leukemia virus challenge for Westman ME, et al. Comparison of three feline leukaemia virus
at least 2 years after vaccination with an inactivated feline leuke- (FeLV) point-of-care antigen test kits using blood and saliva.
mia virus vaccine. Vet Ther. 2010;11:E1. Comp Immunol Microbiol Infect Dis. 2017;50:88.